Clinical trial · Observational
Coronavirus Disease 2019 (COVID-19) Vaccination in Cancer Patients
COVID-19 Vaccination in Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The current study primarily aims to determine the status of vaccination in enrolled cancer patients and identify barriers to coronavirus disease 2019 (COVID-19) vaccination in cancer patients who have not been vaccinated. Secondary objectives include determining the rate of vaccination in those who have ever been COVID-19 positive and those who have never been COVID-19 positive. The study team also seeks to determine factors associated with vaccine-acceptance and vaccine-hesitancy in the adult cancer population, identify side effects of COVID-19 vaccines in vaccinated cancer patients and to examine the effect of COVID-19 vaccination on overall clinical outcome in cancer patients. The study team will be conducting telephone interviews/surveys with up to130 adult cancer patients for data collection.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Malignancies Multiple | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| COVID-19 vaccine hesitancy and acceptance survey | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- interventional
- description
- Single arm, interventional. All participants will be contacted over the phone to answer questions from a COVID-19 vaccine hesitancy and acceptance survey.
- interventionNames
- Other: COVID-19 vaccine hesitancy and acceptance survey
Primary outcomes (2)
- measure
- Rate of COVID-19 vaccination in cancer population
- timeFrame
- 5 months
- description
- To estimate the rate of COVID-19 vaccination in the adult cancer population.
- measure
- Hesitancy to COVID-19 vaccination
- timeFrame
- 5 months
- description
- To identify the reasons of participants' hesitancy to COVID-19 vaccination through questionnaire.
Secondary outcomes (4)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 89 Years
Show eligibility criteria text
Inclusion Criteria: 1. Current or past medical history of invasive malignancy (any type) that has been treated at PSCI 2. Patients who are at least 18-years-old and younger than 90-years-old 3. Patients need to have working telephone /ability to converse. Interpreter could be used to get help with survey if not English speaking. 4. Patients who have had previous COVID-19 infection are also eligible. Exclusion Criteria: 1. Patients who have not been treated or have been seen for current or past medical history of invasive malignancy (any type) at Penn State Cancer Institute 2. Patients who are under the age of 18 and older than 89-years-old 3. Patients who cannot provide consent
References
Publications (0)
Data not yet available